Sort
40,608 grants matching “prostate cancer”
G3BP1 Suppresses SPOP Ubiquitin Ligase to Promote Prostate Tumorigenesis
$484,436Pengbo Zhou · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · CA
Targeting a Novel Signaling Nexus pACK/pCSK/pLCK in Immune Checkpoint Blockade (ICB)-Resistant Prostate Cancer
$484,365Nupam P Mahajan · Washington University · R01 · FY2025 · CA
Targeting a Novel Signaling Nexus pACK/pCSK/pLCK in Immune Checkpoint Blockade (ICB)-Resistant Prostate Cancer
$484,364Nupam P Mahajan · Washington University · R01 · FY2023 · CA
A MOUSE MODEL FOR PROSTATE CANCER
$484,325Univ Of Med/Dent Nj-R W Johnson Med Sch · U01 · FY2001 · CA
Office of Translational Resources
$484,300Thomas A Misteli · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA
Clinical Development of Tacrolimus for Hemorrhagic Cystitis
$484,221Jonathan H Kaufman · Lipella Pharmaceuticals, Inc. · SB1 · FY2018 · DK
Bioengineered Prostate-on Chip: Mechanisms of Stromal Dysregulation in Prostate Cancer
$484,200Cynthia K Miranti · University Of Arizona · R01 · FY2021 · CA
Homologous recombination repair capacity in peripheral blood lymphocytes as a breast cancer risk factor
$484,154Hua Zhao · University Of Virginia · U01 · FY2024 · CA
ONC201/TIC10 Anti-tumor Effect Through Regulation of the TRAIL pathway
$484,099Wafik S El-Deiry · Brown University · R01 · FY2021 · CA
Development of Angiogenesis Inhibitors
$484,095William Douglas Figg · Division Of Clinical Sciences - Nci · ZIA · FY2013 · CA
Development of Drugs That Target Prostate Cancer
$484,095William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Molecularly-Targeted Ultrasound in Ovarian Cancer
$484,088Amelie Lutz · Stanford University · R01 · FY2017 · CA
Tissue/Informatics Core
$483,978Arul M Chinnaiyan · University Of Michigan At Ann Arbor · P50 · FY2009 · CA
A Combination Therapy to Treat Cancer-Related Fatigue
$483,876Sriram Yennu · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
GONADOTROPIN-RELEASING HORMONE ACTION
$483,766Oregon Health And Science University · R37 · FY2003 · HD
Project 2: Combined CAR-T cell therapy
$483,710Gianpietro Dotti · Univ Of North Carolina Chapel Hill · P50 · FY2023 · CA
Nitric Oxide as a Modifier of Oxidative Stress
$483,577David Wink · Division Of Clinical Sciences - Nci · ZIA · FY2020 · CA
Computational Methods for Identifying Non-coding Cancer Drivers
$483,437Ekta Khurana · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · CA
Structure meets function for OATP1B1, a transporter involved in the uptake of endogenous and xenobiotic materials and drugs
$483,347Aviv Paz · Hauptman-Woodward Medical Research Inst · R01 · FY2023 · GM
Drug Discovery for Fatty Acid Synthase in Oncology
$483,337Jeffrey W Smith · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2013 · CA
A New Mechanism for Castration Resistant Prostate Cancer
$483,309Zijie Sun · Stanford University · R01 · FY2015 · CA
Improving breast ultrasound specificity through SFRP2 targeted molecular imaging
$483,305Paul A Dayton · Univ Of North Carolina Chapel Hill · U01 · FY2016 · CA
Understanding the role of an aberrant hepatic nuclear transcription circuit in prostate cancer tumorigenesis and castration resistance
$483,284Yu Chen · Sloan-Kettering Inst Can Research · R01 · FY2018 · CA
GENETIC EPIDEMIOLOGY OF PROSTATE CANCER AGGRESSIVENESS
$483,213Case Western Reserve University · R01 · FY2000 · CA
Specialized Histopathology
$483,210Jon C Aster · Dana-Farber Cancer Inst · P30 · FY2014 · CA